View in EDS

Targeting HSP90 in cancer: advances in the development of inhibitors, mechanisms of action, and therapeutic applications.

Saved in:
Bibliographic Details
Title: Targeting HSP90 in cancer: advances in the development of inhibitors, mechanisms of action, and therapeutic applications.
Authors: Wang X; The First School of Clinical Medicine, Lanzhou University, Lanzhou, China.; Department of General Surgery, The First Hospital of Lanzhou University, Lanzhou, China.; Key Laboratory of Biotherapy and Regenerative Medicine of Gansu Province, Lanzhou, China., Ni R; Institute for Biomedical Engineering, ETH Zurich & University of Zurich, Zurich, Switzerland.; Institute for Regenerative Medicine, University of Zurich, Zurich, Switzerland.; Department of Nuclear Medicine, Inselspital, Bern, Switzerland., Wang X; The First School of Clinical Medicine, Lanzhou University, Lanzhou, China. wangxiaohuia@gdpu.edu.cn.; Department of Nuclear Medicine, The First Hospital of Lanzhou University, Lanzhou, China. wangxiaohuia@gdpu.edu.cn., Li X; The First School of Clinical Medicine, Lanzhou University, Lanzhou, China. lxdr21@126.com.; Department of General Surgery, The First Hospital of Lanzhou University, Lanzhou, China. lxdr21@126.com.; Key Laboratory of Biotherapy and Regenerative Medicine of Gansu Province, Lanzhou, China. lxdr21@126.com.
Source: Molecular cancer [Mol Cancer] 2026 Mar 06; Vol. 25 (1). Date of Electronic Publication: 2026 Mar 06.
Publication Type: Journal Article; Review
Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101147698 Publication Model: Electronic Cited Medium: Internet ISSN: 1476-4598 (Electronic) Linking ISSN: 14764598 NLM ISO Abbreviation: Mol Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41792781
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Targeting HSP90 in cancer: advances in the development of inhibitors, mechanisms of action, and therapeutic applications.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Wang+X%22">Wang X</searchLink>; The First School of Clinical Medicine, Lanzhou University, Lanzhou, China.; Department of General Surgery, The First Hospital of Lanzhou University, Lanzhou, China.; Key Laboratory of Biotherapy and Regenerative Medicine of Gansu Province, Lanzhou, China.<br /><searchLink fieldCode="AU" term="%22Ni+R%22">Ni R</searchLink>; Institute for Biomedical Engineering, ETH Zurich & University of Zurich, Zurich, Switzerland.; Institute for Regenerative Medicine, University of Zurich, Zurich, Switzerland.; Department of Nuclear Medicine, Inselspital, Bern, Switzerland.<br /><searchLink fieldCode="AU" term="%22Wang+X%22">Wang X</searchLink>; The First School of Clinical Medicine, Lanzhou University, Lanzhou, China. wangxiaohuia@gdpu.edu.cn.; Department of Nuclear Medicine, The First Hospital of Lanzhou University, Lanzhou, China. wangxiaohuia@gdpu.edu.cn.<br /><searchLink fieldCode="AU" term="%22Li+X%22">Li X</searchLink>; The First School of Clinical Medicine, Lanzhou University, Lanzhou, China. lxdr21@126.com.; Department of General Surgery, The First Hospital of Lanzhou University, Lanzhou, China. lxdr21@126.com.; Key Laboratory of Biotherapy and Regenerative Medicine of Gansu Province, Lanzhou, China. lxdr21@126.com.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101147698%22">Molecular cancer</searchLink> [Mol Cancer] 2026 Mar 06; Vol. 25 (1). <i>Date of Electronic Publication: </i>2026 Mar 06.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Review
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BioMed+Central%22">BioMed Central </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101147698 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1476-4598 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214764598%22">14764598 </searchLink><i>NLM ISO Abbreviation: </i>Mol Cancer <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41792781
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1186/s12943-025-02559-5
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Targeting HSP90 in cancer: advances in the development of inhibitors, mechanisms of action, and therapeutic applications.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Wang X
      – PersonEntity:
          Name:
            NameFull: Ni R
      – PersonEntity:
          Name:
            NameFull: Wang X
      – PersonEntity:
          Name:
            NameFull: Li X
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 06
              M: 03
              Text: 2026 Mar 06
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1476-4598
          Numbering:
            – Type: volume
              Value: 25
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Molecular cancer
              Type: main
ResultId 1